Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
复制标题
DOI：
10.1161/cir.0b013e318214914f
复制
发表时间：
2011-04-26
期刊：
影响因子：
37.8
通讯作者：
Zierler, Brenda K.
中科院分区：
文献类型：
--
作者：
Jaff, Michael R.;McMurtry, M. Sean;Zierler, Brenda K.
方法成立一个由美国心脏协会外周血管疾病委员会和心肺、危重护理、围手术期和复苏委员会代表组成的写作小组，并由美国心脏协会领导进行审查。所有写作小组成员都被要求披露与行业和与该主题相关的其他实体的所有关系。写作组被细分为3个陈述重点领域，每个小组由一名具有内容专长的成员领导(深静脉血栓形成[SV]、肺栓塞[SZG]和慢性血栓栓塞性肺动脉高压[PAT])。各写作小组系统地审查和总结了相关出版的文献，并将这些资料纳入了一份带有建议草案的手稿。意见分歧是通过面对面的会议以及随后通过电子和电话通信来处理的。最后文件反映了整个委员会的协商一致意见。还指出了不确定的领域，希望基础和临床研究都将促进这一领域的知识。采用美国心脏协会证据等级(表1)。由美国心脏协会任命的外部审查员独立审查了该文件。每项建议都需要编写小组成员在对文件进行外部审查后进行秘密投票。任何与该建议有关的行业有关系的书面团体成员都不参加对该建议的表决。关系的披露包括在本文件中(编写团体披露表)。
MethodsA writing group was established with representation from the Council on Peripheral Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation of the American Heart Association and vetted by American Heart Association leadership. All writing group members were required to disclose all relationships with industry and other entities relevant to the subject. The writing group was subdivided into the 3 areas of statement focus, and each subgroup was led by a member with content expertise (deep venous thrombosis [SV], pulmonary embolism [SZG], and chronic thromboembolic pulmonary hypertension [PAT]). The writing groups systematically reviewed and summarized the relevant published literature and incorporated this information into a manuscript with draft recommendations. Differences in opinion were dealt with through a face-to-face meeting and subsequently through electronic and telephone communications. The final document reflects the consensus opinion of the entire committee. Areas of uncertainty are also noted in hopes that both basic and clinical research will advance knowledge in this area. The American Heart Association Levels of Evidence were adopted (Table 1). External reviewers appointed by the American Heart Association independently reviewed the document. Each recommendation required a confidential vote by the writing group members after external review of the document. Any writing group member with a relationship with industry relevant to the recommendation was recused from the voting on that recommendation. Disclosure of relationships is included in this document (Writing Group Disclosure Table).